These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 15032170

  • 1. Drug for moderate to advanced Alzheimer's approved.
    Mayo Clin Health Lett; 2004 Feb; 22(2):4. PubMed ID: 15032170
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
    Rabins PV, Lyketsos CG.
    Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease.
    Bassil N, Thaipisuttikul P, Grossberg GT.
    Expert Opin Pharmacother; 2010 Jul; 11(10):1765-71. PubMed ID: 20540654
    [Abstract] [Full Text] [Related]

  • 8. Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
    Dent Today; 1997 Feb; 16(2):29. PubMed ID: 9560599
    [No Abstract] [Full Text] [Related]

  • 9. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL, Lladó Plarrumaní A.
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [Abstract] [Full Text] [Related]

  • 10. [The clinical relevance of memantine use].
    Sobów T.
    Psychiatr Pol; 2004 Dec; 38(2):321-30. PubMed ID: 15307296
    [Abstract] [Full Text] [Related]

  • 11. Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease.
    Degerman Gunnarsson M, Kilander L, Basun H, Lannfelt L.
    Dement Geriatr Cogn Disord; 2007 Dec; 24(4):247-52. PubMed ID: 17700020
    [Abstract] [Full Text] [Related]

  • 12. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.
    Grossberg GT, Pejović V, Miller ML, Graham SM.
    Dement Geriatr Cogn Disord; 2009 Dec; 27(2):164-72. PubMed ID: 19194105
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FDA approves memantine drug for treating AD.
    Am J Alzheimers Dis Other Demen; 2003 Dec; 18(6):329-30. PubMed ID: 14682078
    [No Abstract] [Full Text] [Related]

  • 18. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial.
    Pomara N, Ott BR, Peskind E, Resnick EM.
    Alzheimer Dis Assoc Disord; 2007 Dec; 21(1):60-4. PubMed ID: 17334274
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005].
    Wellhöfer B.
    Dtsch Med Wochenschr; 2006 Feb 10; 131(6):284. PubMed ID: 16463237
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.